Seeking Alpha | Sabrient Systems

2024 Was Good: Why 2025 Can Be Even Better

Mon, 12/23/2024 - 11:54

Jazz Pharmaceuticals: Should Sing A Better Tune In 2025

Mon, 12/23/2024 - 11:53

Endeavour Silver: Limited Margin Of Safety At Current Levels

Mon, 12/23/2024 - 11:52

It's Time To Rotate Out Of The S&P 500

Mon, 12/23/2024 - 11:49

Bristol-Myers gets EU okay for Opdivo/Yervoy combo

Mon, 12/23/2024 - 11:46

Volatile Week To Finish Up The Last Monthly Options Expiration Of 2024

Mon, 12/23/2024 - 11:41

X pumps up Premium Plus subscription rate by 37%

Mon, 12/23/2024 - 11:41

S&P 500: A Technical Look At Last Week's Damage

Mon, 12/23/2024 - 11:39

3i Group: Action's Business Model Is A No-Brainer

Mon, 12/23/2024 - 11:38

A. O. Smith: It's Worth Looking Past The Bad News

Mon, 12/23/2024 - 11:37

Week 52: Mismatch Between Interest Rates And Yields Raises Alarm Bells

Mon, 12/23/2024 - 11:36

Columbia Banking System: A Good Dividend Pick With Short-Term Price Uncertainty

Mon, 12/23/2024 - 11:34

Eletrobras: Political And Economic Pressures Mask Improving Efficiency And Undervaluation

Mon, 12/23/2024 - 11:30

Whitestone REIT: Retail Has Finally Right Sized

Mon, 12/23/2024 - 11:30

Morgan Stanley turns more positive on U.S. midcap banks after sector slump

Mon, 12/23/2024 - 11:27

Freeport-McMoRan: Indonesian Reliance Creates A Complicated Investment Case

Mon, 12/23/2024 - 11:24

AstraZeneca gets EU okay for Tagrisso for EGFR lung cancer

Mon, 12/23/2024 - 11:23

RDIV: Not Suitable For Dividend Investors Seeking Stability

Mon, 12/23/2024 - 11:22

BP: A Focus On Shareholder Returns

Mon, 12/23/2024 - 11:00

Marvell: To Join The Big Boys Club - Reiterating Buy

Mon, 12/23/2024 - 10:51